YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis

Journal: Nature Communications

Published: 2019-09-02

DOI: 10.1038/s41467-019-11884-5

Affiliations: 20

Authors: 33

Go to article
Institutions Share
Hopp Children's Tumor Center at NCT Heidelberg (KiTZ), Germany 0.25
Division of Pediatric Neurooncology, DKFZ, Germany 0.23
Milton S. Hershey Medical Center, Penn State, United States of America (USA) 0.08
Queensland Brain Institute (QBI), UQ, Australia 0.06
Division of Molecular Neurogenetics, DKFZ-ZMBH Alliance, Germany 0.06
Department of Pediatrics, Penn State, United States of America (USA) 0.05
Laboratoire de Neuropathologie, CMME, France 0.03
Human Biology Division, FHCRC, United States of America (USA) 0.03
Clinical Cooperation Unit Neuropathology, DKFZ, Germany 0.03
Heidelberg University Hospital at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.03
Division of Molecular Genetics, DKFZ, Germany 0.03
Department of Biochemistry and Cellular Biology, NCNP, Japan 0.03
Department of Pediatric Oncology, Hematology and Immunology at Medical Faculty Heidelberg, Uni Heidelberg, Germany 0.02
Department of Biochemistry and Molecular Biology (BMB), Penn State, United States of America (USA) 0.02
Berlin Institute of Health (BIH), Germany 0.02
German Cancer Research Center in the Helmholtz Association (DKFZ), Germany 0.02
Junior Research Group Pediatric Glioma Research, DKFZ, Germany 0.02
Department of Pharmacology, Penn State, United States of America (USA) 0.01

Return